• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ketamine and Perinatal Mental Health: Problems and Potentials.

作者信息

Swainson Jennifer

机构信息

Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.

Neuroscience and Mental Health Institute, Edmonton, AB, Canada.

出版信息

Can J Psychiatry. 2025 Apr 13:7067437251331514. doi: 10.1177/07067437251331514.

DOI:10.1177/07067437251331514
PMID:40221978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11994625/
Abstract
摘要

相似文献

1
Ketamine and Perinatal Mental Health: Problems and Potentials.氯胺酮与围产期心理健康：问题与潜力
Can J Psychiatry. 2025 Apr 13:7067437251331514. doi: 10.1177/07067437251331514.
2
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.在一组接受急性治疗疗程以管理难治性抑郁症的患者中艾氯胺酮的滥用可能性：一项真实世界临床实践中观察性研究的二次分析
Ther Adv Drug Saf. 2025 Jun 19;16:20420986251347360. doi: 10.1177/20420986251347360. eCollection 2025.
3
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.氯胺酮和其他谷氨酸受体调节剂治疗单相重性抑郁障碍成人患者的抑郁症。
Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3.
4
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.静脉注射消旋氯胺酮与鼻腔内依他佐辛、阿立哌唑和锂盐作为增效治疗难治性单相抑郁的疗效、耐受性和可接受性比较：系统评价和网络荟萃分析。
J Affect Disord. 2024 Feb 1;346:49-56. doi: 10.1016/j.jad.2023.11.023. Epub 2023 Nov 8.
5
Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients.美国医疗补助计划患者中 Esketamine 和 Ketamine 处方的显著地域差异。
J Psychoactive Drugs. 2024 Jan-Mar;56(1):33-39. doi: 10.1080/02791072.2023.2178558. Epub 2023 Mar 1.
6
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review.氯胺酮和 Esketamine 对治疗抵抗性抑郁症的功能结局的疗效：系统评价。
J Affect Disord. 2021 Oct 1;293:285-294. doi: 10.1016/j.jad.2021.06.032. Epub 2021 Jun 24.
7
Comparative efficacy and side-effect profile of ketamine and esketamine in the treatment of unipolar and bipolar depression: protocol for a systematic review and network meta-analysis.比较氯胺酮和艾司氯胺酮治疗单相和双相抑郁症的疗效和副作用：系统评价和网络荟萃分析方案。
BMJ Open. 2021 Feb 12;11(2):e043457. doi: 10.1136/bmjopen-2020-043457.
8
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.依他佐辛鼻喷剂与喹硫平治疗难治性抑郁症的比较。
N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145.
9
Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review.氯胺酮和艾司氯胺酮治疗重度抑郁症时反应和缓解的人口统计学及临床预测因素：一项系统评价
Psychiatry Res. 2025 Mar;345:116355. doi: 10.1016/j.psychres.2025.116355. Epub 2025 Jan 5.
10
Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.依他佐辛和裸盖菇素——两种治疗抑郁症致幻药物的比较：系统评价。
Int J Mol Sci. 2022 Sep 28;23(19):11450. doi: 10.3390/ijms231911450.

本文引用的文献

1
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals.加拿大情绪与焦虑治疗网络2024年围产期情绪、焦虑及相关障碍管理临床实践指南：加拿大情绪与焦虑治疗网络2024年围产期情绪、焦虑及相关障碍治疗实践指南
Can J Psychiatry. 2025 Feb 12:7067437241303031. doi: 10.1177/07067437241303031.
2
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.产后单次低剂量氯胺酮治疗产前抑郁症状的母亲的疗效：随机临床试验。
BMJ. 2024 Apr 10;385:e078218. doi: 10.1136/bmj-2023-078218.
3
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.加拿大心境与焦虑治疗网络（CANMAT）2023 年成人重性抑郁障碍管理临床指南更新：加拿大心境与焦虑治疗网络（CANMAT）2023 年成人重性抑郁障碍管理临床指南更新
Can J Psychiatry. 2024 Sep;69(9):641-687. doi: 10.1177/07067437241245384. Epub 2024 May 6.
4
A First Trimester Exposure to Ketamine and Esketamine for Depression: A Case Report.孕期早期使用氯胺酮和艾司氯胺酮治疗抑郁症：一例报告
J Clin Psychopharmacol. 2024;44(4):429-431. doi: 10.1097/JCP.0000000000001851. Epub 2024 Apr 10.
5
Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis.氯胺酮和艾司氯胺酮对预防剖宫产术后产后抑郁的影响：一项荟萃分析。
J Affect Disord. 2024 Apr 15;351:720-728. doi: 10.1016/j.jad.2024.01.202. Epub 2024 Jan 28.
6
Pharmacokinetics of Ketamine Transfer Into Human Milk.氯胺酮在人乳中的药代动力学。
J Clin Psychopharmacol. 2023;43(5):407-410. doi: 10.1097/JCP.0000000000001711. Epub 2023 May 23.
7
Effects of Perinatal Exposure to Ketamine on the Developing Brain.围产期接触氯胺酮对发育中大脑的影响。
Front Neurosci. 2019 Feb 22;13:138. doi: 10.3389/fnins.2019.00138. eCollection 2019.
8
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.加拿大心境与焦虑治疗网络（CANMAT）和国际双相障碍学会（ISBD）2018 年双相障碍患者管理指南。
Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.